Recombinant follicle stimulating hormone (R-FSH) versus recombinant luteinizing hormone (R-LH) and R-FSH treatment in combination with cetrorelix after oral contraceptive programming in IVF/ICSI; A feasibility study.

van Loenen, ACD; Pirard, Céline; Donnez, Jacques; Huirne, JAF; Schats, R; Lambalk, CB

doi:10.1016/S0015-0282(02)03500-8

Recombinant follicle stimulating hormone (R-FSH) versus recombinant luteinizing hormone (R-LH) and R-FSH treatment in combination with cetrorelix after oral contraceptive programming in IVF/ICSI; A feasibility study.

van Loenen, ACD

;

Pirard, Céline

;

Donnez, Jacques

;

Huirne, JAF

;

Lambalk, CB

;et.al.

(2002) 58th Annual Meeting of the American-Society-for-Reproductive-Medicine — Location: SEATTLE (Washington) (12.October.2002)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
17.52 KB

Request a copy

Details

Authors

van Loenen, ACD
Author
Pirard, CélineUCLouvain
Author
Donnez, JacquesUCLouvain
Author
Huirne, JAF
Author
Lambalk, CB
Author

Affiliations

Citations

APA
Chicago
FWB

van Loenen, A., Pirard, C., Donnez, J., Huirne, J., Schats, R., & Lambalk, C. (2002). Recombinant follicle stimulating hormone (R-FSH) versus recombinant luteinizing hormone (R-LH) and R-FSH treatment in combination with cetrorelix after oral contraceptive programming in IVF/ICSI; A feasibility study. Fertility and Sterility, 78(3), S46-S46. https://doi.org/10.1016/S0015-0282(02)03500-8 (Original work published 2002)